Zdrowie i gospodarka · 01/04/2013

FDA Releases Draft Guidance on Formal Meetings for Biosimilar Biological Products

The Food and Drug Administration (FDA) has published a draft guidance for industry on formal meetings between the agency and sponsors or applicants of biosimilar biological products, aiming to facilitate the development and review process for these regulated products.